Delivery Order SPE2DB24D1007-SPE2DB26FB5PP
Award Date 10/14/25
Potential Completion Date 10/15/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $10,911.36. This firm fixed-price delivery order, set to be completed by September 29, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $5,262.89 on August 22, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $3,516.48. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by July 31, 2025, and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,853.05 on August 7, 2025, for the supply of Novolog 100 Unit/mL Flexpen 3mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. As a child order under a...
- The Defense Logistics Agency awarded a $2,661.40 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This contract represents a competitive, non-set-aside award under a firm fixed-price arrangement with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $2,001.20 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This contract utilizes firm fixed price terms with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,553.22 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This non-competitive delivery order was issued on May 30, 2025, with an ultimate completion date of June 2, 2025, and reflects a firm fixed-price contract structure. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,214.30. This competitively awarded, firm fixed-price delivery order is non-set-aside and represents a portion of AmerisourceBergen's broader pharmaceutical supply mission within the federal healthcare system. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,846.11 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This competitive, firm fixed-price delivery order, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The products will be delivered to AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $2,252.50 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of NovoLog 100 Unit/ML FlexPen 3ML insulin pens, with completion expected by September 17, 2025. This non-set-aside contract employs firm fixed price terms and represents a standard pharmaceutical procurement under the agency's medical supply chain operations. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...